Meta-analyses of global trials finds in favour of aromatase inhibitors
Friday, December 12, 2008 - 05:42
in Health & Medicine
Two separate meta-analyses of clinical trials from around the world that tested tamoxifen against aromatase inhibitor drugs in postmenopausal women with early breast cancer have each reached the same conclusion: aromatase inhibitors are more effective in preventing breast cancer from coming back. Patients using aromatase inhibitors had more than a 3 percent lower cancer recurrence 6-8 years after diagnosis, compared to women using tamoxifen alone...
Read the whole article on Science Centric
More from Science Centric
Related
- Meta-analyses of global trials finds in favor of aromatase inhibitorsThu, 11 Dec 2008, 16:57:26 EST
- Cancer drugs in the pipelineThu, 11 Dec 2008, 16:57:18 EST
- The dietary supplement genistein can undermine breast cancer treatmentTue, 23 Sep 2008, 13:43:29 EDT
- Penn studies point to strategies for reducing painful breast cancer drug side effectsMon, 28 Sep 2009, 11:57:22 EDT
- PET scan can non invasively measure early assessment of treatment for common type of breast cancerTue, 26 May 2009, 12:43:21 EDT